Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Diabetes Mellitus
3:22
The role of regenerative medicine in treating diabetes
Lorenzo Piemonti
• 11 Nov 2021
4:31
The future of regenerative medicine in transplantation
Giuseppe Orlando
• 11 Nov 2021
4:36
Bio-engineering vascularized islet organs for T1D
Lorenzo Piemonti
• 11 Nov 2021
3:34
Challenges in β cell replacement therapy
Lorenzo Piemonti
• 11 Nov 2021
2:34
Advanced cell selection for the manufacture of ProTrans cell therapy
Mathias Svahn
• 6 Oct 2021
1:20
MSCs for type I diabetes
Lindsay Davies
• 7 Jun 2021
2:13
ProTrans: Wharton’s jelly-derived MSC therapy for type I diabetes
Lindsay Davies
• 7 Jun 2021
5:13
Developing the bioartificial pancreas
Ekaterine Berishvili
• 1 Jun 2021
3:54
Tackling remaining obstacles to cell therapy for type I diabetes
Ekaterine Berishvili
• 1 Jun 2021
2:52
The future of cell-based therapies for type 1 diabetes
Ekaterine Berishvili
• 1 Jun 2021
